GGrantIndex
← Search

TREATMENT OF RECURRENT, PLATINUM-RESISTANT OVARIAN CANCER WITH GLUTAMINASE 1 AND PARP INHIBITORS

$1,020,518FY2017Defense Health AgencyDOD

University Of Arkansas For Medical Sciences

Investigators

View source on USAspending →
TREATMENT OF RECURRENT, PLATINUM-RESISTANT OVARIAN CANCER WITH GLUTAMINASE 1 AND PARP INHIBITORS · GrantIndex